Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 8,497-8,508 of 23,847
Drug study icon
CompletedNCT00650429

Ziprasidone for schizophrenia

This study is completed in Mexico. It is testing ziprasidone for schizophrenia.

Multiple locations, including Monterrey
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 70 Years
Countries
Mexico
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia
Drug study icon
TerminatedNCT00645229

Ziprasidone for schizophrenia

This study was terminated in Portugal. It is testing ziprasidone for schizophrenia.

In Lisbon
SchizophreniaDrugFrom 18 Years to 60 Years
Countries
Portugal
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT01640080

Efficacy of Intravenous Esketamine for treatment-resistant depression

This study is completed in Belgium, in Germany, and in Poland. It is testing efficacy of Intravenous Esketamine for treatment-resistant depression.

Multiple locations, including Dave
DepressionDrugFrom 18 Years to 64 Years
Countries
Belgium, Germany, Poland
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
CompletedNCT04115319

Safety study of investigational Drug in schizophrenia

This study is completed in the United States, in Romania, in Russia, .... It is testing investigational Drug for schizophrenia.

Multiple locations, including Cerritos
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Romania, Russia, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00250354

Effectiveness of risperidone in ADHD

This study is completed. It is testing risperidone for ADHD.

Location not clearly listed
ADHDDrugFrom 5 Years to 12 Years
Countries
Sponsor
Janssen Pharmaceutica N.V., Belgium
Condition
ADHD
Drug study icon
CompletedNCT00266552

Effectiveness of risperidone in ADHD

This study is completed. It is testing risperidone for ADHD.

Location not clearly listed
ADHDDrugFrom 5 Years to 12 Years
Countries
Sponsor
Janssen Pharmaceutica N.V., Belgium
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.